Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7
Open Access
Abstract
The skin is an attractive organ for immunization because of the presence of antigen-presenting cells. Intradermal delivery via tattooing has demonstrated superior vaccine immunogenicity of DNA vaccines in comparison to conventional delivery methods. In this study, we explored the efficacy of tattoo injection of a tumor vaccine based on recombinant Semliki Forest virus replicon particles (rSFV) targeting human papillomavirus (HPV). Tattoo injection of rSFV particles resulted in antigen expression in both the skin and draining lymph nodes. In comparison with intramuscular injection, the overall antigen expression determined at the site of administration and draining lymph nodes was 10-fold lower upon tattoo injection. Delivery of SFV particles encoding the E6 and E7 antigens of human papillomavirus type 16 (SFVeE6,7) via tattooing resulted in HPV-specific cytotoxic T cells and in vivo therapeutic antitumor response. Strikingly, despite the observed lower overall transgene expression, SFVeE6,7 delivered via tattoo injection resulted in higher or equal levels of immune responses as compared to intramuscular injection. The intrinsic immunogenic potential of tattooing provides a benefit for immunotherapy based on an alphavirus.Keywords
Funding Information
- KWF Kankerbestrijding (RuG 2008-4066)
This publication has 54 references indexed in Scilit:
- Skin-Resident Antigen-Presenting Cells: Instruction Manual for Vaccine DevelopmentFrontiers in Immunology, 2013
- Virus-Receptor Mediated Transduction of Dendritic Cells by Lentiviruses Enveloped with Glycoproteins Derived from Semliki Forest VirusPLOS ONE, 2011
- Langerhans cells: critical regulators of skin immunity?Immunology & Cell Biology, 2010
- Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different RoutesJournal of Immunotherapy, 2009
- Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practiceExpert Review of Vaccines, 2008
- Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?Vaccine, 2008
- DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvantsGenetic Vaccines and Therapy, 2008
- Langerhans cells cross-present antigen derived from skinProceedings of the National Academy of Sciences, 2006
- Response of mouse skin to tattooing: use of SKH-1 mice as a surrogate model for human tattooingToxicology and Applied Pharmacology, 2005
- Langerhans Cells Migrate to Local Lymph Nodes Following Cutaneous Infection with an ArbovirusJournal of Investigative Dermatology, 2000